132 filings
Page 3 of 7
424B5
vbu6ydrunxy6ysl
8 Aug 23
Prospectus supplement for primary offering
8:13am
424B7
70jhpt5czeqv5qd1
8 Aug 23
Prospectus with selling stockholder info
8:11am
8-K
25uj3
8 Aug 23
Recursion Provides Business Updates and Reports Second Quarter 2023 Financial Results
8:03am
8-K
xw7ts jkh6kv7wghth4
12 Jul 23
Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery
8:32am
8-K
hukkvr
20 Jun 23
Submission of Matters to a Vote of Security Holders
5:09pm
8-K
4s13rq2
13 Jun 23
Regulation FD Disclosure
8:14am
8-K
pkadcg xsmdtz6drz
9 Jun 23
Other Events
7:28am
424B5
hp23xrxwzd
9 Jun 23
Prospectus supplement for primary offering
7:25am
S-8
3184c vk24j8g
30 May 23
Registration of securities for employees
5:14pm
S-3ASR
fq9uayn2d9s
30 May 23
Automatic shelf registration
5:12pm
8-K
inmia7 1f
25 May 23
Regulation FD Disclosure
5:29pm
S-8
hebdn591 xihwwfia7d
17 May 23
Registration of securities for employees
7:23pm
8-K
88attcr
16 May 23
Recursion Appoints David Mauro, M.D., Ph.D., as Chief Medical Officer
9:47pm
S-8
cf0lh6
8 May 23
Registration of securities for employees
4:10pm
8-K
1q7qa4a n344excvzn
8 May 23
Recursion Provides Business Updates and Reports First Quarter 2023 Financial Results
8:18am
8-K
w6y5er9jhhin0l4wx
8 May 23
Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities
8:00am
ARS
tfndjj
28 Apr 23
Annual report to shareholders
9:29am
DEFA14A
fc2qe7
28 Apr 23
Additional proxy soliciting materials
9:27am